Keysight's EISG segment is gaining from AI infrastructure, advanced semiconductors, automotive tech and energy transition demand.

Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.

VRT and TER both benefit from AI demand, but stronger earnings growth and surprises give Teradyne the edge.

The average brokerage recommendation (ABR) for Teradyne (TER) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CSCO's fiscal Q4 earnings and revenues rise y/y as networking demand surges, fueled by AI infrastructure, data center switching and campus growth.

TER's AI-driven robotics growth is accelerating as data center demand boosts automation and semiconductor testing.

AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.

AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.

Teradyne (TER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.